SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Form
Filing Date
Jun 25, 2019
Document Date
Jun 23, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.
Filer
Lyons-Williams Lori